These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 30245957)
1. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer. Li D; Pan Y; Huang Y; Zhang P; Fang X Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957 [TBL] [Abstract][Full Text] [Related]
2. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
3. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671 [TBL] [Abstract][Full Text] [Related]
4. PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells. Park GB; Kim D Anticancer Res; 2017 Apr; 37(4):1805-1818. PubMed ID: 28373445 [TBL] [Abstract][Full Text] [Related]
5. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling. Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230 [TBL] [Abstract][Full Text] [Related]
6. LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway. Gao R; Zhang R; Zhang C; Liang Y; Tang W Anal Cell Pathol (Amst); 2018; 2018():9275685. PubMed ID: 30050750 [TBL] [Abstract][Full Text] [Related]
7. GRP137 promotes cell proliferation and metastasis through regulation of the PI3K/AKT pathway in human ovarian cancer. Zhang LQ; Yang SQ; Qu XD; Chen XJ; Lu HS; Wang Y Tumori; 2018 Oct; 104(5):330-337. PubMed ID: 29739299 [TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway. Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291 [TBL] [Abstract][Full Text] [Related]
9. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
10. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851 [TBL] [Abstract][Full Text] [Related]
11. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway. Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
13. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics. Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288 [TBL] [Abstract][Full Text] [Related]
14. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer. Zhu G; Li X; Guo B; Ke Q; Dong M; Li F Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009 [TBL] [Abstract][Full Text] [Related]
15. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
16. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
17. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway. Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592 [TBL] [Abstract][Full Text] [Related]
18. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP). Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway. Cao J; Li H; Liu G; Han S; Xu P Mol Med Rep; 2017 Sep; 16(3):3600-3605. PubMed ID: 28765957 [TBL] [Abstract][Full Text] [Related]
20. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]